...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cosmetic dermatology >Hypersensitivity reaction to Hyaluronic Acid Dermal filler following novel Coronavirus infection - a case report
【24h】

Hypersensitivity reaction to Hyaluronic Acid Dermal filler following novel Coronavirus infection - a case report

机译：新型冠状病毒感染后对透明质酸皮肤填料的过敏反应 - 一种情况报告

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

The incidence of hypersensitivity reactions to hyaluronic acid dermal fillers is between 0.3 and 4.25%, mediated by T-lymphocytes. Flu-like illness can trigger immunogenic reactions at the site of filler placement. Cases of SARS-CoV-2 are significant and pose a possible risk of inducing hypersensitivity. This case report is of a delayed-type hypersensitivity after hyaluronic acid dermal filler treatment of the nose and subsequent infection with SARS-CoV-2. Risk factors for the development of such symptoms were identified as the presence of hyaluronic acid combined with flu-like illness and repeated treatment of one area. The case resolved without intervention. Clinicians should be mindful of the risk posed by the interaction of hyaluronic acid dermal filler with SARS-CoV-2 in light of the pandemic.
机译：对透明质酸真皮填充物的超敏反应发生率在0.3%到4.25%之间，由T淋巴细胞介导。流感样疾病可在填充物放置部位引发免疫原性反应。SARS-CoV-2病例非常严重，可能有诱发过敏的风险。本病例报告为鼻透明质酸真皮填充物治疗后迟发性超敏反应，随后感染SARS-CoV-2。出现此类症状的风险因素被确定为存在透明质酸，并伴有流感样疾病和反复治疗一个部位。该案未经干预就解决了。鉴于SARS-CoV-2大流行，临床医生应注意透明质酸真皮填充剂与SARS-CoV-2相互作用所带来的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号